Price movement over the last 24 hours
Across Protocol vs Venom — how do they compare? Across Protocol trades at Rp750.87 (market cap Rp525,56M, Rp27,22M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Across Protocol is the larger of the two by market cap, and Across Protocol 's circulating supply is 704,7M / 1B ACX (71%) versus 988,9M / 8B VENOM (13%) for Venom. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 54 Days and Venom for 21 Days on average.
| ACX | VENOM | |
|---|---|---|
Market Cap | Rp525,56M | Rp340,86M |
Volume (24h) | Rp27,22M | Rp2,89M |
Circulating Supply | 704,7M / 1B ACX (71%) | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 54 Days | 21 Days |
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp741.83 with a bearish technical signal, showing sell pressure from moving averages while oscillators remain neutral. The token is currently testing support near Rp731 with resistance at Rp756. With 71% of the 1 million max supply in circulation and an average hold time of 54 days, the token shows moderate distribution stability despite current bearish momentum.
The overall outlook remains cautious due to strong bearish technical indicators, though neutral oscillators suggest potential stabilization. Key opportunities include protocol utility in cross-chain bridging, while major risks involve low liquidity (Rp522.31M market cap) and crypto market volatility. Investors should monitor support levels for potential entry points.
Venom token shows limited market activity with a market cap of Rp340.86M and only 13% circulating supply (988.9M/8M tokens). The asset exhibits low circulation rate with average hold time of 21 days, suggesting limited trading activity. Current technical positioning appears stagnant with minimal price movement data available.
Overall outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunity lies in potential future protocol upgrades, while major risks include extreme volatility from low market cap and regulatory uncertainty in the crypto space.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →